Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Eve Sleep Plc LSE:EVE London Ordinary Share GB00BYWMFT51 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 0.725 90,097 07:30:20
Bid Price Offer Price High Price Low Price Open Price
0.70 0.75 0.725 0.725 0.725
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Personal Goods 26.59 -3.41 -1.12 2
Last Trade Time Trade Type Trade Size Trade Price Currency
08:08:52 O 90,097 0.7015 GBX

Eve Sleep (EVE) Latest News

More Eve Sleep News
Eve Sleep Investors    Eve Sleep Takeover Rumours

Eve Sleep (EVE) Discussions and Chat

Eve Sleep Forums and Chat

Date Time Title Posts
27/6/202213:06EVE - King of Online Mattress Retailing Growing Fast Asos growth rates382
06/4/202214:29EVE Sleep, Rams and Ewes Rutting Thread383
30/11/202114:44EVE covid infested matress clean up391
05/11/202110:17 eve Sleep PLC2,263
26/1/202112:57Evesham goes into administration6

Add a New Thread

Eve Sleep (EVE) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
07:08:530.7090,097632.03O
2022-06-27 14:35:520.70150,0001,051.50O
2022-06-27 13:46:170.7047,052330.54O
2022-06-27 13:00:450.721,244,8518,994.05O
2022-06-27 12:20:570.703,67025.75O
View all Eve Sleep trades in real-time

Eve Sleep (EVE) Top Chat Posts

DateSubject
27/6/2022
09:20
Eve Sleep Daily Update: Eve Sleep Plc is listed in the Personal Goods sector of the London Stock Exchange with ticker EVE. The last closing price for Eve Sleep was 0.73p.
Eve Sleep Plc has a 4 week average price of 0.73p and a 12 week average price of 0.73p.
The 1 year high share price is 5.20p while the 1 year low share price is currently 0.73p.
There are currently 274,294,362 shares in issue and the average daily traded volume is 2,033,633 shares. The market capitalisation of Eve Sleep Plc is £1,988,634.12.
09/6/2022
23:03
gregpeck7: This is against a backdrop of a current sub 3m mkt cap.. I say again, most administrations become asset stripping exercise because there is a debt covenant breach. Not the case here, there is cash in the bank. Any lifestyle brand, M&S , John Lewis, Next, could add EVE to the stable, also DFS etc etc, the transaction would be similar to a rounding error at the current price, even Amazon may be interested, why not, use it as the Amazon mattress range.... I see this is a starter for 10. The thought that this is not a decent buy at 1p per share is just nonsense. Zero Debt Which award winning product range Could Trade profitably in UKI (I would just ditch the foreign adventure) Outstanding range of sleep wellness products Premium and well respected brand Website up and running and a "good" web experience Superb trust pilot rating 30m of revenue per annum Loyal customer base Customer information database
03/4/2022
21:03
geemantw: PS "or they default on debt" – You do know they don't have any debt don't you? There's been a lot of good news coming from eve recently, DFS etc. This was out today. Nothing major but every little helps.. hxxps://cbdsloth.com/reviews/cbd-oil/eve-sleep-cbd-oil-review/ And this on Friday hxxps://www.gq-magazine.co.uk/lifestyle/gallery/weighted-blankets-uk/amp Eve weighted blanket is the winner of that one.
03/4/2022
20:54
geemantw: It's no secret that eve have been making a loss and the statement has appeared in their final results before now (presumably every year) even when the share price was much higher. CC says they are working towards breakeven in UK and EI this year (then sustainable profit) and France is following along the same trajectory. You either believe CC or you don't, which is fine; you are not alone in your belief and that's why the share price is where it is. One 'camp will be right and the other wrong. Currently however, in the case of a company making a loss it seems obligatory to include - and plenty of companies have made losses before making profit - the warning. It is not akin to a prediction of going bust which is what you seem to imply. I would argue that the situation eve finds itself in now is better than any time I've been invested. I found this: 'Material uncertainty related to going concern If appropriate disclosure about the material uncertainty is made in the financial statements, the auditor’s report should include a new section of the audit report with the heading “Material 1 uncertainty related to going concern”. This section will draw attention to the note in the financial statements that discloses this matter and state that these events or conditions indicate that a material uncertainty exists that may cast significant doubt on the company’s ability to continue as a going concern. It will also state that the auditor’s opinion is not modified in respect of the matter. The location for this section is not specified in ISA (UK) 570, but the example in the appendix includes this directly after the basis for opinion section. Note that this is not an emphasis of matter paragraph – under ISA (UK) 570 it is a separate section. Material uncertainty related to going concern We draw attention to Note x in the financial statements, which indicates that the company incurred a net loss of ZZZ during the year ended 31 December 20X1 and, as of that date, the company’s current liabilities exceeded its total assets by YYY. As stated in Note x, these events or conditions, along with other matters as set forth in Note x, indicate that a material uncertainty exists that may cast significant doubt on the company’s ability to continue as a going concern. Our opinion is not modified in respect of this matter.' hxxps://www.icaew.com/-/media/corporate/files/helpsheets/technical/aaf-guides/going-concern-material-uncertainty-relating-to-going-concern.ashx
23/2/2022
20:34
outlawinvestor: Quite a backward step IMO. EVE had previously walked away from similar distribution deals in the past because they don't generate enough revenue and eat up too much margin. It supports the view that EVE is finding it harder to grow UK&I without additional marketing spend. Appears as well, at least for now, that EVE either can't or don't project significant revenue from the partnership hence releasing the news as RNS Reach.
23/2/2022
20:00
smraynot: Non-Regulatory TIDMEVE eve Sleep plc 23 February 2022 eve Sleep plc ("eve" or the "Company") New retail partnership with DFS eve Sleep, the direct to consumer sleep wellness brand operating in the UK, Ireland and France is pleased to announce a new retail partnership with DFS, the market leading retailer of living room and upholstered furniture in the United Kingdom. . Initially the partnership will cover the dfs.co.uk website, which receives an average 2.7 (1) m unique visitors per month. There are also plans to extend the partnership to the DFS showroom estate later in the year. DFS will stock a range of eve mattresses, including eve's Original and Premium Hybrid models rated the two best mattresses in the UK by consumer champion Which?, as well as a range of eve bedframes. Plans are in place to extend the ranges at a later date. Retail partnerships are a tried and tested pillar of eve's omni-channel strategy to be available where its customers shop. The new partnership is expected to drive profitable sales, raise eve's brand and product awareness with its target customer base, and offer DFS customers additional mattress options to choose from, to accompany its bedroom furniture ranges. The partnership is expected to go live on the DFS website from 3 March. John Rastall, Head of DFS Home, commented: "At DFS, we strive to help customers furnish their homes with high quality, stylish and affordable furniture. Our range of bedroom furniture, including our wide choice of upholstered bedframes, is a key and growing part of our offer. We are delighted to be partnering with eve to add their best-in-class mattresses to our range, to support awareness of our bedroom furniture products; deliver even greater choice for our customers; and provide the opportunity for customers to conveniently add an eve mattress to their DFS furniture order." Cheryl Calverley, CEO of eve Sleep commented: "This is a very exciting partnership for eve as DFS seek to extend their 'comfort' positioning beyond the living room and bring eve's award winning mattresses to a wider audience. We're incredibly proud to announce this partnership with the UK's foremost furniture retailer, which recognises the strength of the eve sleep product range and brand, continuing the momentum in our UK&I business." THE ABOVE RNS IS AN AMAZING MOVE AND IMHHO REPRESENTS A MULTI BAGGER BEING THE MONOPOLY GO TO STORE. Must test 5p+ this week as the sensational potential becomes reality.
19/1/2022
11:36
clocktower: One thing I will say is that she can talk the talk but was not very professional holding a mug and drinking while presenting. She also spoke about the share price movement since she started from around 1p - up as high as 7p - well it looks as though it may well go lower than when she started (if she is still there) by the end of 2023 or before if sales slow. The clever thing to do would have to cut costs in H2 and make profit - result higher share price - then raise cash for growth, lacks foresight imo. She has missed the opportunity I believe.
20/12/2021
14:33
clocktower: Get a grip DC 15p maybe but what I have noticed is that EVE have a fair number of jobs advertised, and bearing in mind the company now have a very high rating from staff working under the leadership of the CEO that is turning this into the "Sleep Wellness Brand" that really looks even more positive. Even though the share price is drifting again along with the market, its good to see a few small investors bottom fishing and I believe will be very well rewarded when the next RNS is published in Jan. There are a limited number of shares now available it seems below what the chairman has previously and recently paid for a fair number. Still the companies motto is "Rise and Shine" so I thought it might brighten the day to have a little something lighter on the thread, as I expect we will soon see the share price heading in the other direction. Https://www.youtube.com/watch?v=y4aozLKrcqk Season Greetings.
13/12/2021
07:22
david gruen: Trading update Healthy Black Friday and initial Christmas trading, supply chains solid, in-line with full year expectations eve Sleep ("eve", the "Company"), the direct to consumer sleep wellness brand operating in the UK, Ireland (together "UK&I") and France announces a trading update following the important Black Friday month trading period and ahead of its 31 December year end. The benefits from the Company's completed rebuild strategy continue to come through, with eve on-course to deliver a second consecutive year of revenue growth, in-line with market expectations. Notwithstanding strong November comparatives in the UK, eve's UK e-commerce channel achieved sales order growth in the Black Friday month of 4% year-on-year and 64% when compared to the pre-covid 2019 comparative period. The bedroom furniture category in particular posted strong sales growth in November, up 14% year-on-year, and represented a pleasing 7% of the overall sales mix during this period. Within mattresses, hybrid mattresses remain the outstanding performer, with eve's high performing original and premium hybrid mattresses taking over 70% of the mattress sales share. The new sleep away range performed far ahead of management's expectations, with over GBP50,000 in sales during the month as people prepare for their first Christmas guests in two years. Although currently small in terms of the overall Company, Ireland achieved one of its highest sales months ever in November, delivering 90% growth year-on-year and 480% against 2019 comparatives, reflecting increased focus, market experience and marketing investment. The French market remains soft however, with strength in eve's store based partnership with Olivier Desforges, which reported its highest sales month to date, more than offset by industry wide weakness in e-commerce channels. Generally, in France November and Black Friday is of lesser significance in terms of trading importance compared with some other territories. eve's supply chain has held up well, supported by careful planning and strong relationships with European suppliers and delivery partners, as well as the focus on mattress manufacturing with third party providers in the UK and Belgium. To further ease the pressures on the supply chain and courier partners, whilst maintaining high levels of customer satisfaction, the Company ensured that it offered its Black Friday promotions (of varying levels) over a greater proportion of the month, whilst also holding higher stock levels of core products going into this peak trading period. The Company plans to publish a more comprehensive trading update covering the whole year in January 2022. Cheryl Calverley, CEO of eve Sleep commented: "Following a strong Black Friday trading period and positive signs for Christmas, eve is on-course for a second consecutive year of revenue growth, demonstrating that our recovery is both sustainable and built on strong foundations. Our initial brand expansion beyond mattresses into bedframes is beginning to make a material contribution to revenue, and our wider ranges have continued to expand, further cementing our position as a sleep wellness brand, with recent additions including a non-alcoholic plant based three spirit nightcap drink, the gingko baton low glow night light and a range of CBD oils. I'm so very proud of this team, and the incredible way they work with partners, suppliers and each other to overcome the many and varied supply chain and operational challenges that COVID and Brexit has brought, ensuring that customers can continue to order with confidence. We are looking forward to 2022 with quite some eagerness and feel confident in delivering a third consecutive year of significant progress."
05/11/2021
10:01
david gruen: eve Sleep plc Progressing the sleep wellness repositioning 05/11/2021 9:12am RNS Non-Regulatory TIDMEVE eve Sleep plc 05 November 2021 Eve Sleep plc ("eve" or the "Company") Progressing the sleep wellness repositioning: Update on new products eve Sleep, the direct to consumer sleep wellness brand operating in the UK, Ireland and France provides an update on its recent and pending product launches as part of its broader strategy to further evolve the business, and to become a favoured destination for all things better sleep for better mornings. As part of this strategy a collection of six eve branded CBD drops in Camomile and passionflower, and Ginkgo biloba and ginseng botanical extracts have today gone live on the evesleep.co.uk website. eve is also currently in discussions with a number of leading store based retailers who are interested in stocking the eve CBD oil range. As previously stated, as these oils are sold under a licensing agreement with Sana Lifestyle, eve expects the return will be more from raised brand awareness and the advancement of eve's sleep wellness proposition, rather than revenues and profits. eve has also extended its range of sleep gifting and wellness products in recent weeks, including the non-alcoholic plant based three spirit nightcap drink, the gingko baton low glow night light, a range of eym candles and a selection of rescue remedy products designed to aid a restful night's sleep. In the coming weeks further new products will be launched including a child's version of the very popular Morphee sleep aid and a new long thin hot water bottle. In tandem with the step-up in new product development and introduction, packaging has also been upgraded including the use of fabric bags, for pillows and bedding etc, which are designed to have a second use to further eve's sustainability position. As of today eve now has a product range of over 300 SKU's, of which some 70% are non-mattress products. Cheryl Calverley, CEO of eve Sleep commented: "It takes much more than a wonderful mattress and fabulous bedding to give people the sleep they need to rise and shine, and expanding our range in both consumables and sleep accessories is core to our strategy. These new products offer the opportunity to drive more regular, repeat purchases from existing customers, and increased basket size from new customers, as well as cementing our authority as the only dedicated sleep wellness retailer in the UK."
16/7/2021
07:04
david gruen: 16/07/2021 7:00am UK Regulatory (RNS & others) Eve Sleep plc (EVE) Eve Sleep plc: Trading Update 16-Jul-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- Trading update 13% sales growth in H1, on-course for full year expectations eve Sleep ("eve", the "Company), the direct to consumer sleep wellness brand operating in the UK, Ireland (together "UK &I") and France announces a trading update for the six months ended 30 June 2021. Financial highlights ? Group revenue increased 13% to GBP13.9m (2020: GBP12.2m) ? UK&I revenues increased year-on-year by 18% ? French revenues decreased year-on-year by 8%, as a result of minimal marketing investment in Q1 ahead of the new TV campaign ? Increase in average order values has largely offset intake pricing pressures ? Group marketing contribution and EBITDA losses in line with management's expectations. ? Closing net cash at 30 June 2021 of GBP5.2m (31 December 2020: GBP8.4m) includes GBP0.7m for increased stock holding, repayment of GBP0.3m VAT deferred from Q1 2020 and a seasonal working capital outflow. Strategic and operational highlights ? Launch of major, new French TV campaign 'La vie en jaune' from May ? Further product expansion beyond mattresses including new bed frames, YinYang duvet, bamboo linen bedding, Morphee sleep aid and launch of Sleep Away 'sleepovers' range ? Agreed CBD licensing deal to go live in September as part of product expansion into sleep wellness ? Increased investment in stock to strengthen business resilience and meet peaks in demand ? Appointment of Mike Lloyd as Chairman and Masood Choudhry as Non-Executive Director Good first half performance The UK&I market had a good first half with revenue growth of 18%, notwithstanding more challenging comparatives in the second quarter. Compared with pre pandemic revenues in H1 2019, UK&I sales were 15% higher. Growth was primarily online, with a softer performance from retail partners, reflecting lock down restrictions over the first quarter and to some extent the permanence of channel shift to ecommerce. Demand was particularly strong for eve's hybrid mattress range and premium bed frames, with accessories such as the morphee sleep aid and the weighted blanket, and add-ons such as the temperature balancing protector driving materially higher basket values. eve continues to benefit from the Which? survey which rated eve's original and its premium hybrid the two best mattresses in the UK, and que choisir which ranks the premium hybrid as the best mattress in France. UK marketing investment was front half weighted, increasing to 29% of revenue (2020 H1: 27%) as a result of increased TV advertising, setting up a strong brand position for trading in the second half of the year. In France the majority of the first half of the year was spent preparing for the launch of the new marketing campaign - 'La vie en jaune', which began in May. Ahead of the new campaign, marketing spend was minimal, resulting in revenues for the period marginally lower year-on-year at GBP2.2m. Investment in French marketing is first half weighted, reflecting upfront development costs and was approximately GBP1m in the period. The financial payback on this investment is expected in the second half of the year and over 2022. Early indications from June suggest that the marketing campaign has been well received, with a strong increase in online traffic. Second half outlook Whilst visibility on UK trading conditions for the second half of the year remains limited, the economic recovery looks to be gaining momentum, underpinned by ongoing strength in consumer spending, including on the home. Consumer confidence continues to strengthen and personal savings remain at elevated levels, with fears of mass unemployment abating. These positive demand factors bode well for the retail sector and eve, and as yet the business has seen no signs of a return to pre pandemic shopping behavior, suggesting the online momentum continues. However, the future path of the pandemic is unclear and the risk of further shocks and disruption to the economic recovery remains. As previously set-out in eve's final results on 18 March 2021 there has been some industry supply challenges around raw material inflation and componentry shortages. As expected at the time of the results these pressures have since abated to some degree, and in terms of componentry issues, eve has managed this through the investment in additional stock to ensure customers receive a first-rate service. There may well be further disruption and inflationary pressures, dependent on how the pandemic continues to affect global supply chains. Management anticipate second half revenues in line with expectations and minimal cash outflows. The Company plans to publish its interim results on 23 September 2021. Cheryl Calverley, CEO of eve Sleep commented: "First half revenue growth of 13% is a pleasing result, and in line with our expectations. Our UK business is up 15% on pre pandemic revenue levels reported in H1 of 2019. The balance across sales channels has shifted somewhat, but the overall business is in good health. The start of our investment programme in France has been very encouraging, and we look forward to seeing this campaign power our business performance over the next two years, replicating the progress we have seen in the UK. Maintaining excellent customer service in the face of fluctuating demand and supply chain challenges has been a core focus for us, and the decisions we have taken to improve the resilience of our business through increasing our stock holding and investing in our operational and people capability have undoubtedly underpinned the good H1 performance. We enter the second half of the year with confidence."
Eve Sleep share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
EVE
Eve Sleep
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220628 07:29:15